|
Volumn 348, Issue 6230, 2015, Pages 45-46
|
MULT1plying cancer immunity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MEMBRANE PROTEIN;
MURINE ULBP LIKE TRANSCRIPT 1 PROTEIN;
NATURAL KILLER CELL RECEPTOR;
NATURAL KILLER CELL RECEPTOR NKG2D;
PHOSPHATIDYLINOSITOL 3 KINASE;
RETINOIC ACID;
UNCLASSIFIED DRUG;
CARRIER PROTEIN;
HLA ANTIGEN CLASS 1;
NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;
UL16 BINDING PROTEIN 1, MOUSE;
CANCER;
CELL ORGANELLE;
GENE EXPRESSION;
IMMUNE SYSTEM;
LIGAND;
PROTEIN;
TUMOR;
ANTIGEN RECOGNITION;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CELL COMMUNICATION;
CELL STRESS;
CYTOTOXIC LYMPHOCYTE;
DESENSITIZATION;
DOWN REGULATION;
HUMAN;
IMMUNOCOMPETENT CELL;
INNATE IMMUNITY;
INTRACELLULAR SIGNALING;
LYMPHOCYTE ACTIVATION;
MACROPHAGE;
MAJOR HISTOCOMPATIBILITY COMPLEX;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
TUMOR IMMUNITY;
TUMOR MICROENVIRONMENT;
TUMOR REJECTION;
ANIMAL;
IMMUNOLOGY;
NEOPLASM;
ANIMALS;
CARRIER PROTEINS;
HISTOCOMPATIBILITY ANTIGENS CLASS I;
KILLER CELLS, NATURAL;
NEOPLASMS;
NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;
|
EID: 84927595258
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aaa9842 Document Type: Short Survey |
Times cited : (4)
|
References (14)
|